Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bdfb994cf6cf39a547d9426a6cba0f5b2> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bdfb994cf6cf39a547d9426a6cba0f5b2 NCIT_P378 "NCI" @default.
- Bdfb994cf6cf39a547d9426a6cba0f5b2 type Axiom @default.
- Bdfb994cf6cf39a547d9426a6cba0f5b2 annotatedProperty IAO_0000115 @default.
- Bdfb994cf6cf39a547d9426a6cba0f5b2 annotatedSource NCIT_C102787 @default.
- Bdfb994cf6cf39a547d9426a6cba0f5b2 annotatedTarget "A therapeutic DNA vaccine encoding the E6/E7 fusion protein of human papillomavirus (HPV) subtypes 16 and 18, plus the immune-enhancer, Fms-like tyrosine kinase-3 ligand (FLT3L), with potential immunostimulating and antineoplastic activities. DNA vaccine GX-188E is administered using a proprietary delivery system that electroporates the vaccine into cervical cells. Expression of the E6/E7 fusion product may elicit a cytotoxic T-lymphocyte (CTL) response against cervical cancer cells expressing E6 and E7 oncoproteins, resulting in tumor cell lysis. FLT3L is a ligand for the FLT3 tyrosine kinase receptor, which upon activation stimulates the proliferation of hematopoietic progenitor cells. HPV type 16 and 18 are the most common HPV types involved in cervical carcinogenesis." @default.